Psychotropic medication adherence in correctional facilities: A review of the literature

Journal of Psychiatric and Mental Health Nursing

Volumn 17, Issue 7, 2010, Pages 603-613

  Shelton, D ^a   Ehret, M J ^a   Wakai, S ^a   Kapetanovic, T ^b   Moran, M ^c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b CATHOLIC UNIVERSITY OF AMERICA   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Adherence; Correctional facilities; Mentally ill prisoners; Psychotropic medication

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; HUMAN; MENTAL DISEASE; PATIENT COMPLIANCE; PRISON; RISK FACTOR; SOCIAL ENVIRONMENT;

HUMANS; MEDICATION ADHERENCE; MENTAL DISORDERS; PRISONS; PSYCHOTROPIC DRUGS; RISK FACTORS; SOCIAL ENVIRONMENT;

EID: 77955761074     PISSN: 13510126     EISSN: 13652850     Source Type: Journal    
DOI: 10.1111/j.1365-2850.2010.01587.x     Document Type: Article

References (47)

1. Alia-Klein N, O'Rourke TM, Goldstein RZ. Insight into illness and adherence to psychotropic medications are separately associated with violence severity in a forensic sample. Aggressive Behavior 2007, 33:86-96.
2. Baillargeon J, Contreras S, Grady JJ. Compliance with antidepressant medication among prison inmates with depressive disorders. Psychiatric Services 2000, 51:1444-1446.
3. Bayer R, Stryker J. Ethical challenges posed by clinical progress in AIDS. The American Journal of Public Health 1997, 87:1599-1602.
4. Bressington D, Gray R, Lathlean J. Antipsychotic medication in prisons: satisfaction with and adherence to treatment. Mental Health Practice 2008, 11:18-21.
5. Brink J. Epidemiology of mental illness in a correctional system. Current Opinion in Psychiatry 2005, 18:536-541.
6. Brugha T, Singleton N, Meltzer H. psychosis in the community and in prisons: a report from the British National Survey of psychiatric morbidity. American Journal of Psychiatry 2005, 162:774-780.
7. Day JC, Wood G, Dewey M. Liverpool University neuroleptic side effect rating scale. British Journal of Psychiatry 1995, 166:650-653.
8. Dolder CR, Lacro JP, Jeste DV. Adherence to antipsychotic and non-psychiatric medications in middle-aged and older patients with psychotic disorders. Psychosomatic Medicine 2003, 65:156-162.
9. Farabee D, Shen H, Sanchez S. Program-level predictors of antipsychotic medication adherence among parolees. International Journal of Offender Therapy and Comparative Criminology 2004, 48:561-571.
10. Fazel S, Danesh J. Serious mental disorder in 23 000 prisoners: a systematic review of 62 surveys. The Lancet 2002, 359:545-550.
11. Feder L. A profile of mentally ill offenders and their adjustment in the community. Journal of Psychiatry and Law 1991, 19:79-98.
12. Finnell DS, Osborne FH. Stages of change for psychotropic medication adherence and substance cessation. Archives of Psychiatric Nursing 2006, 20:166-174.
13. Freudenberg N, Daniels J, Crum M. Coming home from jail: the social and health consequences of community reentry for women, male adolescents and their families and communities. American Journal of Public Health 2005, 95:1725-1736.
14. Gavin N, Parson S, Grubin D. Reception screening and mental health needs assessment in a male remand prison. Psychiatric Bulletin 2003, 27:251-253.
15. Gordis L. Methodologic issues in the measurement of patient compliance. Compliance with Therapeutic Regimens 1979, 51-66. Sackett DLHaynes RB. eds, , Johns Hopkins University Press, Baltimore, MD
16. Gray R, Lathlean J, Mills A. Observational cross-sectional pilot study of adherence with antipsychotic medication in people with schizophrenia or schizoaffective disorders in prisons. 2007, Report to the NHS National R&D Programme on Forensic Mental Health
17. Gray R, Bressington D, Lathlean J. Relationship between adherence, symptoms, treatment attitudes, satisfaction, and side effects in prisoners taking antipsychotic medication. Journal of Forensic Psychiatry & Psychology 2008, 19:335-351.
18. Haynes RB, Dantes R. Patient compliance and the conduct and interpretation of therapeutic trials. Controlled Clinical Trials 1987, 8:12-19.
19. Jacoby JE, Kozie-Peak B. The benefits of social support for mentally ill offenders: prison-to-community transitions. Behavioral Science and the Law 1997, 15:483-501.
20. Jordan KB, Schlenger WE, Fairbanks JA. Prevalence of psychiatric disorders among incarcerated women. II. Convicted women felons entering prison. Archives of General Psychiatry 1996, 53:513-519.
21. Julius RJ, Novitsky MA, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. Journal of Psychiatric Practice 2009, 15:34-44.
22. Kane J, Leucht S, Carpenter D. The expert consensus guidelines series; optimizing pharmacologic treatment of psychotic disorders. Journal of Clinical Psychiatry 2003, 64(12):42-47. Suppl.
23. Kozuki Y, Schepp K. Adherence and nonadherence to antipsychotic medications. Issues in Mental Health Nursing 2005, 26:379-396.
24. Lamb RH, Weinberger LE, Gross BH. Community treatment of severely mentally ill offenders under the jurisdiction of the criminal justice system: a review. Psychiatric Services 1999, 50:907-913.
25. Lee C, Connolly PM, Dietz EO. Forensic nurses views regarding medications for inmates. Journal of Psychosocial Nursing and Mental Health Services 2005, 43:32-39. 48-39
26. Leucht S, Barnes TR, Kissling W. Relapse prevention in Schizophrenia with new generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. The American Journal of Psychiatry 2003, 160:1209-1222.
27. Lincoln TM, Wilheim K, Nestoriuc Y. Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis. Schizophrenia Bulletin 2007, 96:232-245.
28. Mahone IH. Medication decision-making by persons with serious mental illness. Archives of Psychiatric Nursing 2004, 18:126-134.
29. Norell SE. Medication behavior: a study of outpatients treated with pilocarpine eye drops of primary open-angle glaucoma. Acta Ophthalmologica 1980, 58(143):1-28. Suppl.
30. Osofsky HJ. Psychiatry behind the walls: mental health services in jails and prisons. Bulletin of the Menninger Clinic 1996, 60:464-479.
31. Osterberg L, Blaschke T. Adherence to medication. The New England Journal of Medicine 2005, 353:487-497.
32. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. Journal of Consulting and Clinical Psychology 1983, 51:390-395.
33. Quanbeck C, Frye M, Altshuler L. Mania and the law in California: understanding criminalization of the mentally ill. American Journal of Psychiatry 2003, 160:1245-1250.
34. Rand CS, Sevick MA. Ethics in adherence promotion and monitoring. Controlled Clinical Trials 2000, 21:241S-247S.
35. Rofail D, Gray R, Gournay K. The development and internal consistency of the Satisfaction with Antipsychotic Medication Scale. Psychological Medicine 2005, 35:1-10.
36. Shelton D, Wakai S, Ehret M. Psychotropic Medication Adherence Among Adult Inmates. 2008, National Commission on Correctional Health Care: Correctional Mental Health - From Innovation to Practice, 13-14 July 2008, Bally's Las Vegas, NV
37. Smith LD. Medication refusal and the rehospitalized mentally ill inmate. Hospital Community Psychiatry 1989, 40:491-496.
38. Solomon P, Draine J, Marcus SC. Predicting incarceration of clients of a psychiatric probation and parole service. Psychiatric Services 2002, 53:50-56.
39. Swanson JW, Van Dorn RA, Monahan J. Violence and leveraged community treatment for persons with mental disorders. American Journal of Psychiatry 2006, 163:1404-1411.
40. Teplin LA. Psychiatric and substance abuse disorders among male urban jail detainees. American Journal of Public Health 1994, 84:290-293.
41. Teplin LA, Abram KM, McClelland GM. Prevalence of psychiatric disorders among incarcerated women: I. Pretrial jail detainees. Archives of General Psychiatry 1996, 53:5005-5012.
42. Thorburn KM. Health care in correctional facilities. Western Journal of Medicine 1995, 163:560-564.
43. Trestman RL, Ford JD, Zhang W. Current and lifetime psychiatric illness among inmates not identified as acutely mentally ill at intake in Connecticut's jails. Journal of the American Academy of Psychiatry and the Law 2007, 35:490-500.
44. Way B, Sawyer D, Kahkejian D. State prison mental health services recipients perception of care survey. Psychiatric Quarterly 2007, 78:269-277.
45. Williams RA, Hollis HM, Benoit K. Attitudes toward psychiatric medications among incarcerated female adolescents. Journal of the American Academy Child Adolescent Psychiatry 1998, 37:1301-1307.
46. Wilper AP, Woolhandler S, Boyd JW. The health and health care of US prisoners: results of a nationwide survey. American Journal of Public Health 2009, 99:666-672.
47. Young DS. Co-occurring disorders among jail inmates: bridging the treatment gap. Journal of Social Work Practice in the Addictions 2003, 3:63-85.